-
-
-
-
-
-
-
Vaxart to present oral vaccine research at World Vaccine Congress Europe
-
-
-
-
-
-
-
Vaxart (VXRT) Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
-
-
-
-
-
-
-
Oppenheimer Reiterates Outperform Rating on Vaxart Inc. (VXRT)
-
-
-
-
-
-
-
Vaxart (VXRT) Provides Business Update
-
-
-
-
-
-
420,184 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

